Michael T Margolis, MD
Gynecological Oncology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
- Since medical school
- 39 years
- University of Kansas School of Med (Kc/Wich/Sal), 1987
Offices
1 location · UCSF Health Medical Foundation · 40 clinicians in this group
Hospitals listed: Community Hospital of the Monterey Peninsula · El Camino Health · Mills-Peninsula Medical Center · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Margolis’s office at (650) 701-1882 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence G83323 · Current
Licensed to practise in California · since 1996 · expires 2027-10-31 · University of Kansas School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$94,995
Medicare paid this office $94,995 for 210 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 119 | $20,483 | $172 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 22 | $12,459 | $566 |
| Repair of pelvic ligaments through vagina | 26 | $8,806 | $339 |
| Long return visit (40+ min) | 49 | $6,921 | $131 |
| Return visit (30+ min) | 52 | $5,880 | $95 |
See all 8 services
| New patient visit (60+ min) | 119 | $20,483 | $172 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 22 | $12,459 | $566 |
| Repair of pelvic ligaments through vagina | 26 | $8,806 | $339 |
| Long return visit (40+ min) | 49 | $6,921 | $131 |
| Return visit (30+ min) | 52 | $5,880 | $95 |
| Short return visit (20+ min) | 56 | $5,095 | $72 |
| Suture suspension of urethra to control leakage using an endoscope | 12 | $4,140 | $345 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $351 | $32 |
Procedures Medicare counted
| Removal of the uterus | 23 | More than 94% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of bladder and urethra using an endoscope | 42 | 39 | 36 | 39 | 33 | 11 |
| Suture suspension of urethra to control leakage using an endoscope | 46 | 39 | 33 | 39 | 29 | 12 |
| Surgical repair of vaginal defect using an endoscope | 39 | 28 | 25 | 32 | 22 | – |
| Repair of pelvic ligaments through vagina | – | 11 | 21 | 26 | 24 | 26 |
| Repair of herniated rectum into vaginal wall | 23 | 17 | 24 | 27 | 16 | – |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 25 | 20 | 14 | 26 | 14 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
210 Original Medicare patients in 2024. Average age 76 · Women 100% · Health risk score 0.88. At or below the middle of the specialty; the typical gynecological oncology clinician is at 1.53.
Conditions among them: High blood pressure 64% · Coronary heart disease 21% · Diabetes 20% · Depression 16% · Cancer 14% · Chronic kidney disease 13% · Atrial fibrillation 10% · Stroke 7% · Heart failure 6%.
The office billed $504,552, Medicare allowed $128,763 and paid $94,995; for 489 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 210 | 489 | 76 | 0.88 | $504,552 | $94,995 |
| 2023 | 242 | 584 | 75 | 0.93 | $646,440 | $132,690 |
| 2022 | 246 | 635 | 75 | 0.87 | $785,232 | $161,990 |
| 2021 | 218 | 575 | 75 | 0.83 | $636,397 | $130,672 |
| 2020 | 221 | 577 | 74 | 0.97 | $694,055 | $124,851 |
| 2019 | 260 | 620 | 73 | 0.87 | $436,469 | $158,613 |
| 2018 | 270 | 700 | 73 | 0.82 | $357,022 | $184,527 |
| 2017 | 288 | 708 | 73 | 0.89 | $314,382 | $172,676 |
| 2016 | 279 | 712 | 73 | 0.89 | $367,391 | $182,699 |
| 2015 | 258 | 701 | 72 | 0.90 | $368,419 | $171,179 |
| 2014 | 229 | 643 | 72 | 0.86 | $315,667 | $155,513 |
| 2013 | 216 | 577 | 73 | 0.82 | $274,264 | $135,226 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| New patient visit (60+ min) | 134 | $24,752 | $185 |
| Surgical repair of vaginal defect using an endoscope | 22 | $18,160 | $825 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 18 | $11,047 | $614 |
| Suture suspension of urethra to control leakage using an endoscope | 29 | $10,556 | $364 |
| Repair of pelvic ligaments through vagina | 24 | $9,315 | $388 |
| Return visit (30+ min) | 64 | $8,552 | $103 |
| Long return visit (40+ min) | 52 | $7,270 | $135 |
| Repair of herniated rectum into vaginal wall | 16 | $4,730 | $296 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 14 | $4,728 | $338 |
| Short return visit (20+ min) | 41 | $4,094 | $82 |
| Diagnostic exam of bladder and urethra using an endoscope | 33 | $1,154 | $35 |
2022: 14 services
| Surgical repair of vaginal defect using an endoscope | 32 | $28,042 | $876 |
| New patient visit (60+ min) | 100 | $19,505 | $195 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 24 | $14,919 | $622 |
| Suture suspension of urethra to control leakage using an endoscope | 39 | $13,827 | $355 |
| Repair of pelvic ligaments through vagina | 26 | $10,695 | $411 |
| Long return visit (40+ min) | 58 | $10,191 | $162 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 26 | $9,210 | $354 |
| Repair of herniated rectum into vaginal wall | 27 | $8,187 | $303 |
| Return visit (30+ min) | 55 | $7,676 | $110 |
| Repair of bladder hernia into vaginal wall | 15 | $6,714 | $448 |
| New patient visit (45+ min) | 59 | $6,513 | $110 |
| Short return visit (20+ min) | 19 | $1,617 | $74 |
| Diagnostic exam of bladder and urethra using an endoscope | 39 | $1,360 | $35 |
| Short return visit | 12 | $483 | $40 |
2021: 13 services
| Surgical repair of vaginal defect using an endoscope | 25 | $21,131 | $845 |
| New patient visit (45+ min) | 142 | $19,521 | $137 |
| Suture suspension of urethra to control leakage using an endoscope | 33 | $13,164 | $399 |
| Return visit (30+ min) | 78 | $11,123 | $109 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 14 | $9,212 | $658 |
| Repair of herniated rectum into vaginal wall | 24 | $8,656 | $361 |
| Repair of pelvic ligaments through vagina | 21 | $7,968 | $379 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 14 | $5,359 | $383 |
| Creation of sling around urethra in female to control leakage | 11 | $4,384 | $399 |
| Short return visit (20+ min) | 38 | $3,994 | $83 |
| Diagnostic exam of bladder and urethra using an endoscope | 36 | $1,255 | $35 |
| Short return visit | 19 | $1,087 | $52 |
| Fitting and insertion of vaginal support device | 13 | $1,046 | $70 |
2020: 11 services
| Surgical repair of vaginal defect using an endoscope | 27 | $23,207 | $829 |
| Suture suspension of urethra to control leakage using an endoscope | 39 | $16,662 | $427 |
| New patient visit (45+ min) | 136 | $16,520 | $121 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 11 | $6,830 | $621 |
| Return visit (30+ min) | 60 | $5,913 | $84 |
| Repair of herniated rectum into vaginal wall | 17 | $5,199 | $306 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 20 | $4,482 | $224 |
| Short return visit (20+ min) | 43 | $2,781 | $56 |
| Repair of pelvic ligaments through vagina | 11 | $2,578 | $234 |
| Diagnostic exam of bladder and urethra using an endoscope | 39 | $1,354 | $35 |
| Short return visit | 19 | $753 | $38 |
2019: 11 services
| Surgical repair of vaginal defect using an endoscope | 39 | $31,679 | $812 |
| New patient visit (45+ min) | 161 | $21,814 | $135 |
| Suture suspension of urethra to control leakage using an endoscope | 46 | $18,896 | $411 |
| Repair of bulging of rectum and bladder into vaginal wall | 25 | $16,954 | $678 |
| Creation of sling around urethra in female to control leakage | 23 | $8,605 | $374 |
| Return visit (30+ min) | 79 | $8,267 | $96 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 25 | $8,099 | $324 |
| Repair of herniated rectum into vaginal wall | 23 | $7,563 | $329 |
| Removal of uterus through vagina, 250.0 g or less | 13 | $4,583 | $353 |
| Short return visit (20+ min) | 29 | $2,085 | $63 |
| Diagnostic exam of bladder and urethra using an endoscope | 42 | $1,478 | $35 |
2018: 12 services
| Surgical repair of vaginal defect using an endoscope | 60 | $49,083 | $818 |
| Suture suspension of urethra to control leakage using an endoscope | 81 | $32,547 | $402 |
| New patient visit (45+ min) | 169 | $22,905 | $136 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 35 | $11,737 | $335 |
| Repair of bulging of rectum and bladder into vaginal wall | 15 | $11,006 | $734 |
| Creation of sling around urethra in female to control leakage | 15 | $6,265 | $418 |
| Repair of herniated rectum into vaginal wall | 20 | $5,393 | $270 |
| Removal of uterus through vagina, 250.0 g or less | 11 | $3,821 | $347 |
| Short return visit (20+ min) | 50 | $3,301 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 80 | $2,877 | $36 |
| Return visit (30+ min) | 23 | $2,429 | $97 |
| Short return visit | 22 | $898 | $37 |
2017: 15 services
| Surgical repair of vaginal defect using an endoscope | 37 | $30,761 | $831 |
| Repair of bulging of rectum and bladder into vaginal wall | 33 | $25,405 | $770 |
| New patient visit (45+ min) | 168 | $22,603 | $135 |
| Suture suspension of urethra to control leakage using an endoscope | 38 | $14,268 | $375 |
| Repair of herniated rectum into vaginal wall | 25 | $11,074 | $443 |
| Creation of sling around urethra in female to control leakage | 28 | $10,354 | $370 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 20 | $7,606 | $380 |
| Short return visit (20+ min) | 68 | $4,631 | $60 |
| Removal or revision of incontinence sling | 11 | $4,466 | $406 |
| Removal of uterus through vagina, 250.0 g or less | 16 | $3,607 | $225 |
| Repair of vaginal wall defect through vagina | 12 | $3,478 | $290 |
| Return visit (30+ min) | 22 | $1,908 | $87 |
| Diagnostic exam of bladder and urethra using an endoscope | 40 | $1,835 | $46 |
| Short return visit | 37 | $1,774 | $39 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $288 | $15 |
2016: 15 services
| Surgical repair of vaginal defect using an endoscope | 46 | $38,929 | $846 |
| Suture suspension of urethra to control leakage using an endoscope | 58 | $24,265 | $418 |
| New patient visit (45+ min) | 169 | $22,723 | $134 |
| Repair of bulging of rectum and bladder into vaginal wall | 23 | $17,888 | $778 |
| Repair of herniated rectum into vaginal wall | 33 | $13,165 | $399 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 23 | $7,858 | $342 |
| Repair of bladder hernia into vaginal wall | 11 | $5,317 | $483 |
| Removal of uterus through vagina, 250.0 g or less | 17 | $5,020 | $295 |
| Creation of sling around urethra in female to control leakage | 12 | $5,001 | $417 |
| Removal or revision of incontinence sling | 11 | $4,546 | $413 |
| Diagnostic exam of bladder and urethra using an endoscope | 61 | $3,429 | $56 |
| Short return visit (20+ min) | 39 | $2,619 | $62 |
| Short return visit | 51 | $2,464 | $38 |
| Return visit (30+ min) | 21 | $1,975 | $94 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $214 | $18 |
2015: 14 services
| Surgical repair of vaginal defect using an endoscope | 41 | $33,508 | $817 |
| Suture suspension of urethra to control leakage using an endoscope | 55 | $23,375 | $425 |
| New patient visit (45+ min) | 162 | $22,854 | $141 |
| Repair of bulging of rectum and bladder into vaginal wall | 18 | $13,997 | $778 |
| Repair of herniated rectum into vaginal wall | 23 | $8,999 | $391 |
| Creation of sling around urethra in female to control leakage | 16 | $6,936 | $433 |
| Removal or revision of incontinence sling | 16 | $5,589 | $329 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 17 | $4,158 | $245 |
| Removal of uterus through vagina, 250.0 g or less | 14 | $3,942 | $282 |
| Diagnostic exam of bladder and urethra using an endoscope | 56 | $3,109 | $55 |
| Short return visit (20+ min) | 47 | $3,106 | $61 |
| Repair of pelvic ligaments through vagina | 13 | $2,891 | $222 |
| Short return visit | 51 | $2,431 | $40 |
| Return visit (30+ min) | 22 | $2,228 | $89 |
2014: 16 services
| New patient visit (45+ min) | 135 | $19,183 | $142 |
| Suture suspension of urethra to control leakage using an endoscope | 40 | $17,894 | $447 |
| Surgical repair of vaginal defect using an endoscope | 23 | $16,429 | $714 |
| Repair of bulging of rectum and bladder into vaginal wall | 19 | $15,471 | $814 |
| Repair of herniated rectum into vaginal wall | 21 | $9,037 | $430 |
| Creation of sling around urethra in female to control leakage | 21 | $8,365 | $398 |
| Repair of pelvic ligaments through vagina | 28 | $6,830 | $244 |
| Removal of uterus through vagina, 250.0 g or less | 18 | $5,605 | $311 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $3,930 | $327 |
| Short return visit (20+ min) | 41 | $2,450 | $60 |
| Diagnostic exam of bladder and urethra using an endoscope | 41 | $2,316 | $56 |
| Return visit (30+ min) | 19 | $1,904 | $91 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $1,323 | $110 |
| Short return visit | 31 | $1,162 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $929 | $77 |
| Electronic assessment of bladder emptying | 12 | $90 | $7 |
2013: 13 services
| Surgical repair of vaginal defect using an endoscope | 23 | $17,902 | $778 |
| New patient visit (45+ min) | 117 | $16,442 | $141 |
| Repair of bulging of rectum and bladder into vaginal wall | 18 | $14,097 | $783 |
| Suture suspension of urethra to control leakage using an endoscope | 33 | $13,719 | $416 |
| Creation of sling around urethra in female to control leakage | 23 | $9,446 | $411 |
| Repair of pelvic ligaments through vagina | 28 | $6,159 | $220 |
| Removal of uterus through vagina, 250.0 g or less | 20 | $5,793 | $290 |
| Repair of herniated rectum into vaginal wall | 16 | $5,521 | $345 |
| Removal or revision of incontinence sling | 14 | $5,251 | $375 |
| New patient visit (60+ min) | 17 | $3,050 | $179 |
| Short return visit | 49 | $2,354 | $40 |
| Short return visit (20+ min) | 32 | $2,109 | $54 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $1,937 | $59 |
Drugs they prescribed that Part D paid
$19,613
Pharmacies billed $19,613 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (88 of 671) in 2024. At or below the middle of the specialty; the typical gynecological oncology clinician is at 13%.
623 generic and fewer than 11 brand-name prescriptions · $19,613 in drug cost · 131 antibiotic prescriptions to 73 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Imipramine | 252 | $2,631 | $10 |
| Estradiol | 31 | $2,134 | $69 |
| Solifenacin | 20 | $1,528 | $76 |
| Naproxen | 61 | $914 | $15 |
| Nitrofurantoin Mono-Macro | 71 | $762 | $11 |
See all 9 drugs
| Imipramine | 252 | $2,631 | $10 |
| Estradiol | 31 | $2,134 | $69 |
| Solifenacin | 20 | $1,528 | $76 |
| Naproxen | 61 | $914 | $15 |
| Nitrofurantoin Mono-Macro | 71 | $762 | $11 |
| Hydrocodone-Acetaminophen | 55 | $389 | $7 |
| Nitrofurantoin | 27 | $216 | $8 |
| Acetaminophen-Codeine | 30 | $145 | $5 |
| Ciprofloxacin | 14 | $76 | $5 |
Year by year
| 2024 | 671 | 187 | 13% (88) | None | $19,613 |
| 2023 | 650 | 198 | 15% (98) | None | $18,728 |
| 2022 | 502 | 178 | 21% (104) | None | $17,799 |
| 2021 | 406 | 159 | 22% (89) | None | $15,587 |
| 2020 | 420 | 152 | 22% (92) | None | $13,604 |
| 2019 | 430 | 162 | 24% (105) | None | $10,919 |
| 2018 | 454 | 181 | 27% (123) | 24% | $15,338 |
| 2017 | 442 | 178 | 26% (116) | 17% | $18,419 |
| 2016 | 445 | 174 | 28% (124) | 20% | $27,043 |
| 2015 | 404 | 145 | 31% (124) | 24% | $22,905 |
| 2014 | 394 | 131 | 27% (105) | None | $20,788 |
| 2013 | 363 | 120 | 24% (88) | None | $15,903 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Imipramine | 221 | $2,541 | $11 |
| Tolterodine Tartrate Er | 18 | $2,314 | $129 |
| Estradiol | 11 | $1,708 | $155 |
| Naproxen | 53 | $1,444 | $27 |
| Oxybutynin Chloride Er | 20 | $1,368 | $68 |
| Nitrofurantoin Mono-Macro | 82 | $1,255 | $15 |
| Nitrofurantoin | 27 | $881 | $33 |
| Hydrocodone-Acetaminophen | 70 | $488 | $7 |
| Naproxen | 13 | $128 | $10 |
| Acetaminophen-Codeine | 22 | $95 | $4 |
2022: 9 drugs
| Premarin | 17 | $4,284 | $252 |
| Estradiol | 15 | $2,507 | $167 |
| Imipramine | 141 | $1,773 | $13 |
| Oxybutynin Chloride Er | 23 | $1,685 | $73 |
| Nitrofurantoin Mono-Macro | 73 | $1,235 | $17 |
| Solifenacin | 14 | $1,053 | $75 |
| Naproxen | 23 | $717 | $31 |
| Hydrocodone-Acetaminophen | 79 | $622 | $8 |
| Acetaminophen-Codeine | 17 | $93 | $5 |
2021: 8 drugs
| Estradiol | 16 | $1,804 | $113 |
| Nitrofurantoin Mono-Macro | 89 | $1,242 | $14 |
| Oxybutynin Chloride Er | 15 | $1,162 | $77 |
| Imipramine | 71 | $977 | $14 |
| Nitrofurantoin | 26 | $849 | $33 |
| Hydrocodone-Acetaminophen | 71 | $650 | $9 |
| Ciprofloxacin | 18 | $142 | $8 |
| Acetaminophen-Codeine | 15 | $100 | $7 |
2020: 6 drugs
| Imipramine | 98 | $2,038 | $21 |
| Nitrofurantoin Mono-Macro | 104 | $1,535 | $15 |
| Nitrofurantoin | 24 | $866 | $36 |
| Hydrocodone-Acetaminophen | 71 | $770 | $11 |
| Acetaminophen-Codeine | 16 | $117 | $7 |
| Ciprofloxacin | 26 | $117 | $4 |
2019: 6 drugs
| Nitrofurantoin Mono-Macro | 106 | $1,778 | $17 |
| Imipramine | 104 | $1,143 | $11 |
| Hydrocodone-Acetaminophen | 90 | $952 | $11 |
| Oxybutynin Chloride Er | 12 | $551 | $46 |
| Fluconazole | 11 | $129 | $12 |
| Ciprofloxacin | 11 | $79 | $7 |
2018: 7 drugs
| Tolterodine Tartrate Er | 17 | $3,830 | $225 |
| Nitrofurantoin Mono-Macro | 130 | $3,025 | $23 |
| Hydrocodone-Acetaminophen | 96 | $1,218 | $13 |
| Imipramine | 87 | $998 | $11 |
| Oxybutynin Chloride Er | 11 | $398 | $36 |
| Ciprofloxacin | 25 | $174 | $7 |
| Acetaminophen-Codeine | 23 | $161 | $7 |
2017: 7 drugs
| Tolterodine Tartrate Er | 27 | $6,411 | $237 |
| Premarin | 12 | $5,419 | $452 |
| Nitrofurantoin Mono-Macro | 120 | $2,198 | $18 |
| Imipramine | 103 | $889 | $9 |
| Hydrocodone-Acetaminophen | 78 | $681 | $9 |
| Acetaminophen-Codeine | 33 | $237 | $7 |
| Ciprofloxacin | 16 | $139 | $9 |
2016: 7 drugs
| Tolterodine Tartrate Er | 18 | $7,036 | $391 |
| Vesicare | 16 | $6,946 | $434 |
| Nitrofurantoin Mono-Macro | 101 | $2,131 | $21 |
| Imipramine | 96 | $1,282 | $13 |
| Hydrocodone-Acetaminophen | 77 | $1,122 | $15 |
| Acetaminophen-Codeine | 44 | $324 | $7 |
| Ciprofloxacin | 11 | $112 | $10 |
2015: 8 drugs
| Tolterodine Tartrate Er | 18 | $6,847 | $380 |
| Vesicare | 21 | $5,427 | $258 |
| Premarin | 13 | $2,580 | $198 |
| Nitrofurantoin Mono-Macro | 98 | $1,908 | $19 |
| Imipramine | 67 | $1,191 | $18 |
| Hydrocodone-Acetaminophen | 61 | $866 | $14 |
| Acetaminophen-Codeine | 52 | $303 | $6 |
| Ciprofloxacin | 15 | $120 | $8 |
2014: 10 drugs
| Premarin | 18 | $4,033 | $224 |
| Tolterodine Tartrate Er | 14 | $3,444 | $246 |
| Vesicare | 14 | $3,320 | $237 |
| Nitrofurantoin Mono-Macro | 87 | $2,370 | $27 |
| Hydrocodone-Acetaminophen | 64 | $1,108 | $17 |
| Imipramine | 72 | $920 | $13 |
| Oxybutynin Chloride | 11 | $124 | $11 |
| Oxycodone-Acetaminophen | 13 | $124 | $10 |
| Ciprofloxacin | 12 | $97 | $8 |
| Acetaminophen-Codeine | 17 | $92 | $5 |
2013: 6 drugs
| Detrol La | 15 | $4,242 | $283 |
| Vesicare | 16 | $4,144 | $259 |
| Nitrofurantoin Mono-Macro | 74 | $2,203 | $30 |
| Imipramine | 107 | $1,509 | $14 |
| Hydrocodone-Acetaminophen | 70 | $745 | $11 |
| Ciprofloxacin | 12 | $117 | $10 |
Money from drug and device companies
$190 in 2025
| 2025 | 2 | 2 | None | $190 |
| 2023 | 3 | 3 | None | $68 |
| 2022 | 3 | 6 | None | $119 |
| 2021 | 7 | 9 | None | $195 |
| 2020 | 4 | 5 | None | $92 |
| 2019 | 6 | 9 | None | $176 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Coloplast | Meals · 2025-12-02 | Titan | $172 |
| Medtronic | Meals · 2025-03-13 | Rapidvac | $18 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $68
| Abbott Laboratories | Proclaim | $24 | 1 payment
|
| Axonics | Axonics | $23 | 1 payment
|
| Coloplast | Saffron | $21 | 1 payment
|
2022: $119
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $63 | 3 payments
|
| Abbvie | Lo Loestrin Fe | $38 | 2 payments
|
| TherapeuticsMD | Annovera | $19 | 1 payment
|
2021: $195
| AbbVie | Orilissa | $73 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $30 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
| Roche Diagnostics | Cintec Plus Cytology | $19 | 1 payment
|
| Myovant Sciences | Myfembree | $19 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $18 | 1 payment
|
| Mayne Pharma | None | $16 | 1 payment
|
2020: $92
| Acell | None | $32 | 2 payments
|
| AbbVie | Orilissa | $24 | 1 payment
|
| Roche Diagnostics | Rs Harmony Test Related Products | $19 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $18 | 1 payment
|
2019: $176
| AbbVie | Orilissa | $89 | 4 payments
|
| Roche Diagnostics | Rs Harmony Test Related Products | $19 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $19 | 1 payment
|
| TherapeuticsMD | Imvexxy | $19 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $18 | 1 payment
|
| Exeltis USA | Vitafol Ultra | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1467475046
- Licence
- CA G83323California G83323: Current · expires 2027-10-31
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 1987 · 39 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA GR0101630
- Taxonomy
- Federal specialty code 207VG0400X (207VG0400X); Federal specialty code 2088F0040X (2088F0040X)
- Mailing address
- 101 S San Mateo Dr Ste 102, San Mateo, CA, 94401
- NPI first listed
- 2006-07-25
- NPI last updated
- 2023-10-26
- NPI record certified
- 2022-12-13
This is when the NPI record was last certified, not a medical board exam.